Peptide Reference Database#

The Peptide Reference Database is a comprehensive clinical reference tool for practitioners prescribing peptide therapies. It covers dosing protocols, mechanisms of action, clinical indications, administration routes, and safety considerations — available without leaving the Qliva platform.

Who can access it#

Access to the Peptide Reference Database is restricted to practitioners with prescribing scope — GPs and nurses with prescribing rights. Practitioners without prescribing access will not see the database in their sidebar or on prescribing screens.

This access control is intentional: peptide prescribing is a specialised clinical area and the database contains detailed dosing and administration information.

Two ways to access the database#

1. Standalone page#

Navigate to Clinical Tools → Peptide Database in the left sidebar. This opens the full database in a standalone page at /peptide-database.

Use this view when you want to browse or research without an active prescription — for example, before a consultation, or to answer a patient's general question about a peptide.

2. Slide-over panel on prescribing screens#

On any of the three prescribing screens — the prescriptions list, the new prescription form, and the eRx prescription detail page — a Peptide Database button appears in the top-right corner.

Clicking this button opens the database as a slide-over panel that sits alongside your prescription without navigating away. This is the primary workflow for using the database during active prescribing: you can check the protocol for a peptide and fill in the prescription details side by side.

What the database contains#

The database is organised by peptide and covers:

• Mechanism of action — how the peptide works at a physiological level
• Clinical indications — the evidence base and common clinical applications
• Dosing protocols — standard dosing ranges, frequency, and duration
• Administration routes — subcutaneous, intranasal, oral (where applicable), and reconstitution guidance
• Side effects and contraindications — known adverse effects and patient populations to exercise caution with
• Stacking protocols — where evidence supports combination use
• Storage requirements — temperature, light sensitivity, reconstituted stability

Searching and browsing#

The database has a search bar for finding peptides by name or alias. You can also browse by category — metabolic, hormonal, tissue repair, cognitive, performance, and others.

Selecting a peptide opens its full monograph with all the above fields.

Updating the database#

The database content is maintained by the Qliva team. To suggest additions, corrections, or new peptide entries, contact support@qliva.com.au with the peptide name and supporting literature.

To update the database, the Qliva team replaces the database source file — no code changes are required. Updates are reflected immediately after deployment.

TGA compliance note#

Peptide therapies in Australia exist in a regulatory grey area. Many peptides are not TGA-registered medicines and are prescribed as compounded or imported preparations. Practitioners are responsible for ensuring that any peptide they prescribe complies with current TGA regulations and their professional obligations under AHPRA.

The Peptide Reference Database provides reference information only — it does not imply or confirm TGA registration, PBS listing, or clinical endorsement by Qliva.